| Back |
|
| A therapy that efficiently covers the Broader spectrum of pathogens |
| Product Name: |
| Tablets |
| Ofloxacin 200/400 mg , 100 mg dispersable tablets |
| Ensures broader reach with efficient action |
| Better than ceftriaxone in enteric fever - An open randomised trial, treatment of uncomplicated enteric fever with oral ofloxacin resulted in complete cure of all 22 patients, whereas only 18 of 25 patients treated with intravenous ceftriaxone were completely cured (p<0.01) |
| Easier switch therapy - One recent study suggested that switch therapy from intravenous to oral ofloxacin was easier to implement then sequential therapy from an intravenous regimen to a different oral formulation. |
| High Cure rates in UTI - 3 or 5 day courses of oral ofloxacin produced bacteriological response rates ranging from 80 to 99% in patients with uncomplicated urinary tract infections. |
| Effective in PID - Ofloxacin for a total of 10 to 14 days achieved clinical or bacteriological response rates of 98 or 100% in patients with uncomplicated PID |
| Excellent result in Gonorrhoea - Single dose achieved bacteriological response rates of 97 to 100% in patients with uncomplicated gonorrhoea. |
|
|
| GI tract infections
|
| Acute bacterial exacerbations of chronic bronchitis
|
| Cummunity-acquired pneumonia
|
| Uncomplicated skin and skin structure infections
|
| Acute, uncomplicated urethral and cervical gonorrhea
|
| Mixed infections of the urethra and cervix
|
| Acute pelvic inflammatory disease
|
| Uncomplicated cystitis
|
| Complicated urinary tract infections
|
| Prostatitis
|
|
Medical Jr.
| 1. Ref; Drugs 1999; 58 Suppl.2
|
| 2. Drugs 1998 Nov; 56(5)
|
| 3. Drugs 1998 nov; 56(5): 895-928
|
|
| |
|
 |